ScholarGate
Assistente

Comparar métodos

Examine os métodos selecionados lado a lado; as linhas que diferem ficam destacadas.

Ensaio Clínico Fase III Pareado×Propensity Score Matching×
ÁreaEpidemiologiaEstatística para pesquisa
FamíliaProcess / pipelineProcess / pipeline
Ano de origemMid-20th century (matching in RCTs formalized ~1950s–1970s)1983
Autor originalFisher, R. A. (matching principles); adapted into confirmatory trial design over mid-20th centuryPaul Rosenbaum and Donald Rubin
TipoControlled confirmatory clinical trial with matchingMethod
Fonte seminalRothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗
Outros nomesmatched controlled Phase III trial, Phase III matched-pair trial, matched confirmatory trial, matched late-phase RCTPSM, propensity score weighting, covariate balance
Relacionados53
ResumoA matched Phase III clinical trial is a confirmatory, late-stage controlled study in which each participant assigned to the experimental treatment is paired with one or more controls who share key prognostic characteristics — such as age, disease stage, or comorbidities — before treatment allocation. By ensuring baseline comparability at the level of matched pairs, the design reduces confounding and improves statistical efficiency in settings where simple randomization alone may produce imbalanced groups or where full randomization is logistically or ethically constrained.Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias.
ScholarGateConjunto de dados
  1. v1
  2. 2 Fontes
  3. PUBLISHED
  1. v1
  2. 3 Fontes
  3. PUBLISHED

Ir para a pesquisa Baixar slides

ScholarGateComparar métodos: Matched Phase III Clinical Trial · Propensity Score Matching. Recuperado em 2026-06-19 de https://scholargate.app/pt/compare